View Post

Have your say on RAIRD services

In News by John Geddes

Have your say on the way your services are working for your Rare Autoimmune Rheumatic Disease (RAIRD) At least 170,000 people in the UK live with rare autoimmune rheumatic diseases …

View Post

Covid Boosters

In News by John Geddes

Spring COVID Vaccine 2024 booster eligibility The government has announced a Spring 2024 dose of COVID-19 vaccine for: Those eligible should be offered an appointment between April and June by …

View Post

VAS-UP: study on steroid toxicity

In News by John Geddes

VAS-UP: “UPgrading multilevel methods of assessing toxicity from steroids in VASculitis and other related conditions“ The researchers would welcome your participation in phase 1b of this Oxford University study. They are …

View Post

Ramadan Autoimmune Health Survey 

In News by John Geddes

A doctor and student are trying to find out more about the impact of fasting in Ramadan on the health of patients with vasculitis and other similar autoimmune diseases. The …

View Post

Schools Prize – “Science in Medicine”

In News by John Geddes

Inspiring the scientists of tomorrow Vasculitis UK is so pleased to announce that we have co-sponsored the Fourth Annual “Science in Medicine School Teams Prize” to engage sixth-form school students with …

View Post

Results of symptoms survey

In News by John Geddes

Vasculitis UK helped recruit a population of patients with vasculitis (with or without neuropathy) to complete an anonymous online survey for research on symptoms associated with neuropathy, led by Michael …

View Post

A very different study

In News by John Geddes

The University of Nottingham is running a study, funded by Vasculitis UK, into how mental imagery and art can improve our health. They are looking for “Eight people living with …

View Post

VUK speakers at UKIVAS course

In News by John Geddes

UKIVAS (UK and Ireland Vasculitis Rare Disease Group) held a Vasculitis Educational Course in Manchester on 20th/21st November 2023. The course was attended by around 70 attendees including junior doctors, …